NCT06095739View on ClinicalTrials.gov

Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

November 18, 2022

Primary Completion Date

January 2, 2023

Study Completion Date

January 2, 2023

Conditions
Hair DiseasesAlopeciaHair Loss
Interventions
COMBINATION_PRODUCT

DA-OTC-002

"The topical formula of DA-OTC-002 was formed from 2 molecules: an alpha 1 agonist (synephrine) and a TAAR receptor agonist~A 1mL topical application of DA-OTC-002 was applied to a 10cm x 10xm target area of the right side of the scalp of each subject"

Trial Locations (1)

Unknown

Hospital Oscar Nicolau, Manaus

Sponsors
All Listed Sponsors
lead

Applied Biology, Inc.

INDUSTRY